HM

HealthCor Management Portfolio holdings

AUM $109M
This Quarter Return
+9.13%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.44B
AUM Growth
+$2.44B
Cap. Flow
-$376M
Cap. Flow %
-15.43%
Top 10 Hldgs %
44.28%
Holding
112
New
29
Increased
17
Reduced
20
Closed
38

Top Buys

1
REGN icon
Regeneron Pharmaceuticals
REGN
$106M
2
CVS icon
CVS Health
CVS
$106M
3
BMY icon
Bristol-Myers Squibb
BMY
$98.5M
4
TMO icon
Thermo Fisher Scientific
TMO
$92.3M
5
NTRA icon
Natera
NTRA
$89.7M

Top Sells

1
VRTX icon
Vertex Pharmaceuticals
VRTX
$111M
2
INCY icon
Incyte
INCY
$93M
3
AGIO icon
Agios Pharmaceuticals
AGIO
$79.2M
4
ABBV icon
AbbVie
ABBV
$78.9M
5
IQV icon
IQVIA
IQV
$77.6M

Sector Composition

1 Healthcare 90.66%
2 Consumer Discretionary 4.55%
3 Real Estate 2.63%
4 Financials 1.91%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ABGI
51
DELISTED
ABG Acquisition Corp. I Class A Ordinary Shares
ABGI
$3.23M 0.13%
329,400
-20,600
-6% -$202K
GLPG icon
52
Galapagos
GLPG
$2.05B
$2.83M 0.11%
41,080
+6,820
+20% +$470K
OMEG
53
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.7M 0.11%
271,038
-103,962
-28% -$1.03M
SRSAU
54
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
$2.69M 0.11%
262,150
– –
CYT
55
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$2.57M 0.1%
+120,000
New +$2.57M
EUCRU
56
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$2.39M 0.1%
234,180
-100,000
-30% -$1.02M
DAWN icon
57
Day One Biopharmaceuticals
DAWN
$758M
$2.36M 0.09%
+103,717
New +$2.36M
GLUE icon
58
Monte Rosa Therapeutics
GLUE
$304M
$2.27M 0.09%
+100,000
New +$2.27M
MRUS icon
59
Merus
MRUS
$5.01B
$2.03M 0.08%
96,438
+35,948
+59% +$757K
JNCE
60
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.82M 0.07%
268,295
+65,710
+32% +$447K
JYAC
61
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$1.4M 0.06%
140,680
– –
ATAI icon
62
ATAI Life Sciences
ATAI
$984M
$1.39M 0.06%
+75,000
New +$1.39M
ELEV
63
DELISTED
Elevation Oncology
ELEV
$1.36M 0.05%
+100,000
New +$1.36M
BHVN
64
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.07M 0.04%
+11,000
New +$1.07M
LGV.WS
65
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$585K 0.02%
+427,178
New +$585K
MREO
66
Mereo BioPharma
MREO
$281M
$473K 0.02%
149,170
– –
EQRXW
67
DELISTED
EQRx, Inc. Warrant
EQRXW
$258K 0.01%
+99,998
New +$258K
OHPAW
68
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$131K 0.01%
+137,305
New +$131K
MSACW
69
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$83K ﹤0.01%
+82,663
New +$83K
ABBV icon
70
AbbVie
ABBV
$374B
– –
-729,420
Closed -$78.9M
ACAD icon
71
Acadia Pharmaceuticals
ACAD
$4.33B
– –
-900,490
Closed -$23.2M
AGIO icon
72
Agios Pharmaceuticals
AGIO
$2.28B
– –
-1,532,960
Closed -$79.2M
ALLO icon
73
Allogene Therapeutics
ALLO
$249M
– –
-494,640
Closed -$17.5M
ANIK icon
74
Anika Therapeutics
ANIK
$132M
– –
-13,540
Closed -$552K
AUPH icon
75
Aurinia Pharmaceuticals
AUPH
$1.54B
– –
-950,000
Closed -$12.3M
1 2
3
4 5